MELK Antikörper (AA 66-629) (Cy3)
Kurzübersicht für MELK Antikörper (AA 66-629) (Cy3) (ABIN8007924)
Target
Alle MELK Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 66-629
-
Verwendungszweck
- Anti-MELK Antibody Cy3 Conjugated
-
Kreuzreaktivität (Details)
- No cross-reactivity with other proteins.
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human MELK recombinant protein (Position: H66-Q629).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Flow Cytometry, 1-3 μg/1x106 cells
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Haltbarkeit
- 12 months
-
-
- MELK (Maternal Embryonic Leucine Zipper Kinase (MELK))
-
Andere Bezeichnung
- MELK
-
Hintergrund
-
Background: Maternal embryonic leucine zipper kinase (MELK) is an enzyme that in humans is encoded by the MELK gene. Maternal embryonic leucine-zipper kinase (MELK) is a key regulator of survival of stemlike GBM cells in vitro. MELK expression is increased in breast cancer tissue and this increase is also associated with poor patient survival, as predicted for a candidate oncogene.
Gene Full Name: maternal embryonic leucine zipper kinase
-
Gen-ID
- 9833
-
UniProt
- Q14680
Target
-